Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care Co's ROE % for the quarter that ended in Mar. 2026 was 12.06%. SWS Hemodialysis Care Co's PB Ratio for the quarter that ended in Mar. 2026 was 2.62.
SWS Hemodialysis Care Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 4.60%.
SWS Hemodialysis Care Co ROE % Adjusted to Book Value Related Terms
SWS Hemodialysis Care Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for SWS Hemodialysis Care Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co ROE % Adjusted to Book Value Chart
SHSE:688410 vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 4.60% mean?
SWS Hemodialysis Care Co (SHSE:688410) has a ROE % Adjusted to Book Value of 4.60% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SWS Hemodialysis Care Co and its competitors.
Is SWS Hemodialysis Care Co's ROE % Adjusted to Book Value too high?
SWS Hemodialysis Care Co's current ROE % Adjusted to Book Value is 4.60%. Overall, SWS Hemodialysis Care Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's ROE % Adjusted to Book Value compare to ISRG and BDX?
SWS Hemodialysis Care Co's ROE % Adjusted to Book Value of 4.60% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SWS Hemodialysis Care Co and its competitors. SWS Hemodialysis Care Co's current ROE % Adjusted to Book Value is 4.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.44, compared to a current price of ¥10.59 — trading 31.4% below its estimated fair value. The current ROE % Adjusted to Book Value is 4.60%. SWS Hemodialysis Care Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current ROE % Adjusted to Book Value is 4.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.59 is trading 31.4% below its estimated GF Value™ of ¥15.44.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
ROE % Adjusted to Book Value: 4.60%
GF Value™: ¥15.44 vs. price of ¥10.59 (31.4% below fair value)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
88GF Score
Get the complete analysis for SHSE:688410
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
